NYSE:PATH

UiPath (PATH) Stock Forecast, Price & News

$17.18

+0.07 (+0.41%)

(As of 12:51 PM ET)

Compare

Today's Range: $17.00
▼
$17.42
50-Day Range: $14.57
▼
$19.18
52-Week Range: $10.40
▼
$19.94

Volume: 2.84 million shs
Average Volume: 7.79 million shs
Market Capitalization: $9.74 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $19.84

UiPath MarketRank™ Forecast

Analyst Rating: Hold
2.40 Rating Score
Upside/Downside: 15.4% Upside
$19.84 Price Target
Short Interest: Bearish
10.57% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.43
Based on 17 Articles This Week
Insider Trading: Selling Shares
$4.71 M Sold Last Quarter
Proj. Earnings Growth: Growing
From ($0.28) to ($0.27) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.02 out of 5 stars

Business Services Sector

193rd out of 317 stocks

Prepackaged Software Industry

130th out of 208 stocks

3.2

Analyst's Opinion

Consensus Rating
UiPath has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 6 buy ratings, 9 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $19.84, UiPath has a forecasted upside of 15.4% from its current price of $17.20.
Amount of Analyst Coverage
UiPath has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

1.0

Short Interest

Percentage of Shares Shorted
10.57% of the float of UiPath has been sold short.
Short Interest Ratio / Days to Cover
UiPath has a short interest ratio ("days to cover") of 5.8.
Change versus previous month
Short interest in UiPath has recently increased by 0.44%, indicating that investor sentiment is decreasing.

0.0

Dividend Strength

Dividend Yield
UiPath does not currently pay a dividend.
Dividend Growth
UiPath does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for PATH.

3.0

News and Social Media Coverage

News Sentiment
UiPath has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Business Services companies.
News Coverage This Week
MarketBeat has tracked 17 news articles for UiPath this week, compared to 7 articles on an average week.
Search Interest
70 people have searched for PATH on MarketBeat in the last 30 days. This is an increase of 30% compared to the previous 30 days.
MarketBeat Follows
45 people have added UiPath to their MarketBeat watchlist in the last 30 days. This is an increase of 96% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, UiPath insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $4,707,786.00 in company stock.
Percentage Held by Insiders
31.03% of the stock of UiPath is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
59.04% of the stock of UiPath is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for UiPath are expected to grow in the coming year, from ($0.28) to ($0.27) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of UiPath is -53.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of UiPath is -53.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
UiPath has a P/B Ratio of 4.99. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About UiPath (NYSE:PATH) Stock

UiPath Inc. is a leading software company specializing in robotic process automation (RPA) technology. Headquartered in New York City, but founded in Bucharest, Romania, UiPath offers a comprehensive platform that automates repetitive tasks and enables businesses to operate more efficiently. The company was founded in 2005 by Romanian entrepreneurs Daniel Dines and Marius Tirca and has since grown to become a significant player in the RPA industry. UiPath has received numerous awards and accolades, including being named a leader in the Gartner Magic Quadrant for RPA Software in 2020.

UiPath's executive team is led by Chief Executive Officer and co-founder Daniel Dines, who has been with the company since its inception. Daniel is considered one of the pioneers of robotic process automation, helping start the industry. Mr. Dines contributes to his success in the industry by being relentless and constantly exposing himself to the industry's uncertainties. Other key management team members include Chief Financial Officer Ashim Gupta and Chief Marketing Officer Bobby Patrick. In 2021, UiPath announced that former Microsoft executive Tom Clancy would join as its new Senior Vice President of Learning.

UiPath has experienced significant growth in recent years, with revenue increasing exponentially since its inception. The company's net loss has been decreasing yearly. As of January 31, 2021, UiPath has cash, cash equivalents, and short-term investments capable of covering liabilities indicating that the company is working to keep control of its debt. UiPath's valuation has fluctuated since its IPO, with the company's market capitalization reaching a high of over $45 billion in May 2021 before falling to around $10 billion in Q4 of 2022. UiPath's price-to-sales ratio is higher than the industry average. Since its IPO in April 2021, UiPath's stock price has been volatile, with shares reaching a high of $90 in May 2021 before dropping to around $10 in November 2022. Since hitting its all-time low price, the stock has rebounded. Trading volume has also been relatively high, with an average of over 6 million shares traded per day.

The robotic process automation industry has experienced rapid growth in recent years as businesses seek to automate manual processes and increase efficiency. UiPath competes with several other robotic process automation providers, including Automation Anywhere, Blue Prism, and WorkFusion. In addition, the industry is subject to regulatory and political pressures, particularly around data privacy and security.

UiPath has identified several critical areas for growth, including expanding its product offerings to include artificial intelligence and machine learning capabilities and targeting new industries such as healthcare and financial services. The company has also been actively pursuing acquisitions, with recent purchases including Cloud Elements and ProcessGold.

As the robotic process automation industry continues to evolve, UiPath may face challenges from competitors who can offer similar or better technology at a lower cost. In addition, regulatory and political pressures may create uncertainty for the industry, which could impact UiPath's growth prospects.

PATH Price History

30 days | 90 days | 365 days | Advanced Chart

PATH Stock News Headlines

September 15, 2023 | insidertrades.com

Institutions Make Big Bets On AI Stocks With Profits (PATH)

September 12, 2023 | marketbeat.com

2 Leading AI Stocks Going Opposite Ways (PATH)

Artificial intelligence (AI) has driven the new enterprise demand cycle for servers, services and applications; some companies are meeting demand, some are not

October 2, 2023 | PressReach (Ad)

Nuclear Revival Creates Opportunities for Uranium

Uranium companies set to benefit from increased demand for clean energy.

September 11, 2023 | marketbeat.com

The Top 5 Analysts Calls in September (PATH)

These stocks have more in common than analysts' attention. Read on to find out why these are the Most Upgraded Stocks for the 1st week of September.

September 8, 2023 | marketbeat.com

AI 2.0 is Here: How to Invest in a Generational Opportunity (PATH)

AI is sweeping the world but don't confuse apples with oranges; here's a look at the top 5 advancements in AI and who is using it.

September 7, 2023 | marketbeat.com

The Top 5 Robot Stocks Automating Investment Returns Now (PATH)

AI is hot and nowhere hotter than the applications that use it, including physical and software robots that automate business processes.

September 6, 2023 | marketbeat.com

7 Best Robotics Stocks to Buy Now (PATH)

What are the best robotics stocks to buy now, as AI continues to influence many sectors? Learn more about the best robotics stocks to buy now with MarketBeat.

October 2, 2023 | forbes.com

Culture Is Built One Behavior At A Time

October 2, 2023 | Behind the Markets (Ad)

U.S. Loses to China in Shocking WAR GAMES

=== BREAKING === U.S. Loses to China in Shocking WAR GAMES Pentagon says new "living missile" key to winning a future conflict. Investors stand to reap 35,960% on shares of the small defense contractor that makes powerful new weapon. Get the name of the stock here >>>

September 30, 2023 | barrons.com

UiPath Investor Deadline Approaching

September 30, 2023 | americanbankingnews.com

UiPath (NYSE:PATH) Earns "Sector Perform" Rating from Royal Bank of Canada

September 29, 2023 | barrons.com

PATH Class Action Lawsuit: If You Lost Money in UiPath, Inc., Contact Robbins LLP for Information About Your Rights

September 29, 2023 | benzinga.com

SHAREHOLDER ALERT: Levi & Korsinsky Notifies UiPath Inc. (PATH) Investors of a Class Action Lawsuit and Upcoming Deadline

September 29, 2023 | markets.businessinsider.com

DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in UiPath Inc. with Losses of $100,000 to Contact the Firm

September 28, 2023 | markets.businessinsider.com

The Latest Analyst Ratings for UiPath

September 28, 2023 | finance.yahoo.com

This Cathie Wood AI Stock Looks Like a Screaming Buy

September 28, 2023 | americanbankingnews.com

Rich Wong Sells 100,000 Shares of UiPath Inc. (NYSE:PATH) Stock

September 27, 2023 | investorplace.com

UiPath Director Rich Wong Just Sold 100,000 Shares of PATH Stock

September 27, 2023 | msn.com

UiPath director sells $1.64M in common stock

September 26, 2023 | finance.yahoo.com

Should Investors Buy UiPath Stock Right Now?

September 25, 2023 | msn.com

Ark Invest: UiPath and Twilio over Nvidia as stocks to consider

September 24, 2023 | theglobeandmail.com

ROSEN, A RESPECTED AND LEADING FIRM, Encourages UiPath, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PATH

September 24, 2023 | markets.businessinsider.com

UiPath Ongoing Deadline Alert

September 22, 2023 | benzinga.com

PATH Investors Have Opportunity to Lead UiPath Inc. Securities Fraud Lawsuit

September 22, 2023 | americanbankingnews.com

UiPath Inc. (NYSE:PATH) Receives Average Rating of "Hold" from Analysts

September 21, 2023 | barrons.com

UIPATH, INC. (NYSE: PATH) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against UiPath, Inc.

September 20, 2023 | benzinga.com

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of UiPath Inc. - PATH

See More Headlines

Receive PATH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UiPath and its competitors with MarketBeat's FREE daily newsletter.

PATH Company Calendar

Last Earnings: 9/06/2023
Today: 10/02/2023
Next Earnings (Estimated): 12/07/2023
Fiscal Year End: 1/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Prepackaged software
Sub-Industry: N/A
Sector: Business Services
Current Symbol: NYSE:PATH
CUSIP: N/A
CIK: 1375200
Web: www.uipath.com
Phone: 844-432-0455
Fax: N/A
Employees: 3,833
Year Founded: 2005

Price Target and Rating

Average Stock Price Forecast: $19.84
High Stock Price Forecast: $27.50
Low Stock Price Forecast: $16.00
Forecasted Upside/Downside: +16.0%
Consensus Rating: Hold
Rating Score (0-4): 2.40
Research Coverage: 15 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($0.32)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-328,350,000.00
Net Margins: -15.47%
Pretax Margin: -14.66%
Return on Equity: -7.49%
Return on Assets: -5.47%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 4.45
Quick Ratio: 4.45

Sales & Book Value

Annual Sales: $1.15 billion
Price / Sales: 8.45
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.50 per share
Price / Book: 4.89

Miscellaneous

Outstanding Shares: 566,738,000
Free Float: 390,879,000
Market Cap: $9.70 billion
Optionable: Not Optionable
Beta: 0.69

Social Links

10 Best Stocks to Own in 2023

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Daniel Solomon Dines (Age 51)
Co-Founder, Co-CEO & Chairman
Comp: $771.84k

Mr. Robert Enslin (Age 60)
Co-Chief Exec. Officer
Comp: $1.29M

Mr. Ashim Gupta (Age 44)
Chief Financial Officer
Comp: $799.57k

Mr. Brad C. Brubaker (Age 59)
Gen. Counsel, Chief Legal Officer & Sec.
Comp: $663.85k

Hitesh Ramani
Chief Accounting Officer

Ms. Kelsey Doherty Turcotte
Sr. VP of Investor Relations

Mr. Robert B. Patrick (Age 51)
Chief Marketing Officer

Mr. Vijay Khanna
Chief Corp. Devel. Officer

Ms. Brigette McInnis-Day
Chief People Office

Mr. Munil Shah
Chief Technology Officer of Automation Cloud

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

PATH Stock - Frequently Asked Questions

Should I buy or sell UiPath stock right now?: 15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 9 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" PATH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PATH, but not buy additional shares or sell existing shares.
View PATH analyst ratings or view top-rated stocks.
What is UiPath's stock price forecast for 2023?: 15 brokerages have issued twelve-month price targets for UiPath's stock. Their PATH share price forecasts range from $16.00 to $27.50. On average, they predict the company's share price to reach $19.84 in the next twelve months. This suggests a possible upside of 16.0% from the stock's current price.
View analysts price targets for PATH or view top-rated stocks among Wall Street analysts.
How have PATH shares performed in 2023?: UiPath's stock was trading at $12.71 at the beginning of 2023. Since then, PATH shares have increased by 34.6% and is now trading at $17.11.
View the best growth stocks for 2023 here.
When is UiPath's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, December 7th 2023.
View our PATH earnings forecast.
How were UiPath's earnings last quarter?: UiPath Inc. (NYSE:PATH) released its quarterly earnings data on Wednesday, September, 6th. The healthcare company reported $0.09 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.05. The healthcare company had revenue of $287.31 million for the quarter, compared to analyst estimates of $281.48 million. UiPath had a negative trailing twelve-month return on equity of 7.49% and a negative net margin of 15.47%. The business's revenue was up 18.6% compared to the same quarter last year. During the same period in the previous year, the company posted ($0.18) EPS.
What ETFs hold UiPath's stock?: ETFs with the largest weight of UiPath (NYSE:PATH) stock in their portfolio include ARK Autonomous Technology & Robotics ETF (ARKQ), ARK Innovation ETF (ARKK), ARK Fintech Innovation ETF (ARKF), ARK Next Generation Internation ETF (ARKW), ARK Space Exploration & Innovation ETF (ARKX), SoFi Be Your Own Boss ETF (BYOB), SoFi Be Your Own Boss ETF (GIGE) and Global X Robotics & Artificial Intelligence Thematic ETF (BOTZ).
What guidance has UiPath issued on next quarter's earnings?: UiPath updated its third quarter 2024 earnings guidance on Wednesday, September, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $313.00 million-$318.00 million, compared to the consensus revenue estimate of $315.33 million.

When did UiPath IPO?: (PATH) raised $990 million in an initial public offering (IPO) on Wednesday, April 21st 2021. The company issued 21,300,000 shares at $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities served as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers.
What is UiPath's stock symbol?: UiPath trades on the New York Stock Exchange (NYSE) under the ticker symbol "PATH."
How do I buy shares of UiPath?: Shares of PATH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is UiPath's stock price today?: One share of PATH stock can currently be purchased for approximately $17.11.
How much money does UiPath make?: UiPath (NYSE:PATH) has a market capitalization of $9.70 billion and generates $1.15 billion in revenue each year. The healthcare company earns $-328,350,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis.
How many employees does UiPath have?: The company employs 3,833 workers across the globe.
Does UiPath have any subsidiaries?: The following companies are subsidiares of UiPath: Cloud Elements, Cloud Elements Inc., CloudElements Technologies India Private Limited, MagnaView BV, ProcessGold A.G., ProcessGold B.V., ProcessGold International B.V., Re:infer, Shanghai Zhicheng Technology Co. Ltd., StepShot, The Conundrum IP LLC, UiPath AB, UiPath Australia Pty Ltd, UiPath Austria GmbH, UiPath Belgium BVBA, UiPath Brasil Consultoria Limitada, UiPath Business Solutions India Private Limited, UiPath Canada Operations Ltd., UiPath Denmark ApS, UiPath Finland Oy, UiPath France SAS, UiPath GMBH, UiPath Inc., UiPath Israel LTD, UiPath Italy SRL, UiPath Kabushiki Kaisha, UiPath Korea Ltd., UiPath Limited (Hong Kong), UiPath Ltd. (UK), UiPath Mexico S. DE R.L. DE C.V., UiPath Netherlands B.V., UiPath Netherlands Holding B.V., UiPath Norway AS, UiPath OOO, UiPath PTE LTD, UiPath Process Mining, UiPath Robotic Process Automation India Private Limited, UiPath SRL, UiPath South Africa (Pty) LTD, UiPath Switzerland GmbH, UiPath Ukraine LLC, and UiPath Ventures LLC.
Read More
How can I contact UiPath?: UiPath's mailing address is 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States. The official website for the company is www.uipath.com. The healthcare company can be reached via phone at 844-432-0455 or via email at investor.relations@uipath.com.

This page (NYSE:PATH) was last updated on 10/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial